Morpheahttps://en.wikipedia.org/wiki/Morphea
Morphea jẹ fọọmu ti scleroderma ti o mu awọ le pọ si lori oju, ọwọ, ati ẹsẹ, tabi nibikibi miiran lori ara, laisi ilowosi awọn ara inu. Morphea jẹ nipọn ati lile ti awọ ara ati awọn tissu abẹ awọ-ara lati ifasilẹ collagen pupọ. Morphea yato si lati "systemic sclerosis (systemic sclerosis)" nipa aini ilowosi awọn ara inu.

☆ AI Dermatology — Free Service
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
  • Egbo ti Morphea maa han bí apá àìlera tí ó ní àwọ̀ dídá.
  • Scleroderma laini iwaju (Frontal linear scleroderma)
  • Scleroderma laini iwaju (Frontal linear scleroderma)
  • Ìfarapa (lesion) dudu ati funfun pẹlu tinrin (tabi ipare) jẹ ifura ti Morphea.
References Localized scleroderma: clinical spectrum and therapeutic update 25672301 
NIH
Scleroderma jẹ arun ti o ṣọwọn ti o kan awọn ara asopọ, ti n ṣafihan bi awọ lile ati nigbakan ni ipa awọn ẹya miiran ti ara. Awọn oriṣi akọkọ meji lo wa: systemic sclerosis, eyiti o jẹ pẹlu líle awọ ara ati awọn ara inu, ati localized scleroderma, ti a tun mọ ni morphea, eyiti o maa wa ni opin si awọ ara ati awọn ara ti o wa labẹ rẹ, pẹlu ilana alaabo ati ti ara ẹni ti o lopin. Botilẹjẹpe scleroderma ti agbegbe jẹ to ṣọwọn ati idi rẹ ko mọ, iwadi aipẹ ṣe imọran pe o tun le ni ipa lori awọn ara inu ati ja si ọpọlọpọ awọn ọran ilera. Itọju tete jẹ pataki lati yago fun awọn ilolu, fun iwulo agbara ti localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
 Upcoming treatments for morphea 34272836 
NIH
Morphea , tun mọ bi scleroderma ti agbegbe, jẹ arun autoimmune ti o ṣọwọn ti o kan asopọ. O le ṣe afihan ni awọn ọna oriṣiriṣi, ati pe ko wọpọ, pẹlu awọn iṣẹlẹ 0.4-2.7 fun eniyan 100,000 ni ọdun kọọkan. Morphea nigbagbogbo ni a rii ni awọn ọmọde laarin ọdun 2 si 14, ati pe o maa n kan awọn ọmọbirin ni igbagbogbo ju awọn ọmọkunrin lọ.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.